title: Correlation of the Rutgeerts score and recurrence of Crohn's disease in patients with end ileostomy.
abstract: Recurrence of Crohn's disease (CD) can occur after surgery, including end ileostomy (EI). The Rutgeerts score (RS) was developed to predict postsurgical CD recurrence via ileocolonoscopy in patients having ileocolonic resection. The role of ileoscopic evaluation via stoma for assessing recurrence of CD has not been investigated. The aim of this study was to evaluate the role of ileoscopy for predicting disease recurrence in CD patients after EI with the use of RS.
  
  
  
  A total of 73 eligible CD patients with at least two ileoscopies in our institution following EI were included. Mucosal inflammation of the neo-terminal ileum was graded based on the RS. The primary outcomes were the need for endoscopic stricture dilation and subsequent surgery due to recurrence of disease. The secondary outcomes were CD-related hospitalization and the need to escalate CD-associated medications.
  
  
  
  The median duration of CD until EI was 9 years (interquartile range: 4-13 years), and the median duration from EI to the first ileoscopy was 28 months (interquartile range: 11-93 months). The RSs in the neo-terminal ileum close to EI were calculated, and subjects were divided into two groups: the normal RS group with the score being zero (n = 25) and the abnormal RS group with the RS score being ≥1 (n = 48). Patients in the abnormal RS group were more likely to have recurrence of CD (92% vs 27%) and need endoscopic dilation of stricture (40% vs 10%), subsequent bowel surgery (68% vs 15%), disease-related hospitalizations (80% vs 23%) and escalation of CD medications (64% vs 25%) than those in the normal RS group. Time-to-event analysis showed that patients in the abnormal RS group were at a higher risk of endoscopic dilation (odds ratio (OR) = 1.5; 95% CI: 1.09-1.9), need of second bowel surgery (OR = 1.5; 95%CI: 1.2-1.8) and disease-related hospitalizations (OR = 1.3; 95%CI: 1.1-1.6) after adjusting for factors such as duration from surgery to sensor, duration of disease and the patient's sex (all P < 0.001). Further multivariable analysis showed that patients in the abnormal RS group were more likely to need escalation of CD-related medications after adjusting for duration from surgery and age (OR = 5.3; 95% CI: 1.7-16.5; P = 0.004).
  
  
  
  RS can be used to predict the recurrence of CD in patients with EI. A high RS score based on ileoscopy appeared to be associated with poor outcomes. This may be considered a useful decision-making tool for monitoring disease after ileostomy surgery.
authors.affiliation: Department of Internal Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA.
authors.forename: Vasutakarn
authors.initials: V
authors.lastname: Chongthammakun
authors.affiliation: Department of Internal Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA.
authors.forename: Andre
authors.initials: A
authors.lastname: Fialho
authors.affiliation: Department of Internal Medicine, The Cleveland Clinic Foundation, Cleveland, OH, USA.
authors.forename: Andrea
authors.initials: A
authors.lastname: Fialho
authors.affiliation: Department of Quantitative Health Sciences, The Cleveland Clinic Foundation, Cleveland, OH, USA.
authors.forename: Rocio
authors.initials: R
authors.lastname: Lopez
authors.affiliation: The Center for Inflammatory Bowel Diseases, The Cleveland Clinic Foundation, Cleveland, OH, USA shenb@ccf.org.
authors.forename: Bo
authors.initials: B
authors.lastname: Shen
keywords: Crohn’s disease; Rutgeerts score; ileoscopy; ileostomy; recurrence